40 likes | 53 Views
The L-carnitine market is projected to grow at a considerable CAGR of around 4% during the forecast period (2020-2026). The proper intake of L-carnitine on daily basis facilitates weight management, which is the primary cause of obesity. The L-carnitine supplements are used to offer relief in obesity-related disorders such as diabetes, high blood pressure, heart diseases, and stroke among others. The global adult diabetic population was 425 million in 2018 with the prevalence rate reaching 8.5% as per World Health Organization (WHO). Over 1.6 million mortalities occurred due to diabetes across the globe. L-carnitine aid to prevent damage caused by too much sugar in the body, therefore growing diabetes patients encourages the demand for L-carnitine.
E N D
Orion Market Research Global L-Carnitine Market:Industry Growth, Size, Share and Forecast 2020-2026 Request a Free Sample of Report on Global L-Carnitine Market @ https://www.omrglobal.com/request- sample/l-carnitine-market -------------------------------------------------------------------------------------------------------------------------------------------------- Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780304040
The L-carnitine market is projected to grow at a considerable CAGR of XX% during the forecast period (2020- 2026). L-carnitine is an amino acid that turns fat into energy. L-carnitine is mainly taken by individuals to increase L-carnitine levels in their bodies. The proper intake of L-carnitine is found to be effective in several conditions including serious kidney disease, overactive thyroid, complications in conceiving, strain in heart and blood vessels and so on. The proper intake of L-carnitine supplements offers relief in obesity-related disorders such as diabetes, high blood pressure, heart diseases, and stroke among others. A full Report of Global L-Carnitine Market at https://www.omrglobal.com/industry-reports/l-carnitine- market Diabetes is one of the major health issues all across the globe and it has reached alarming levels. As per the International Diabetes Foundation (IDF), around 463 million have diabetes globally in 2019. The global prevalence of diabetes is projected to augment to 578 million by 2030, and 700 million by 2045. Moreover, around two-thirds of people having diabetes live in urban areas. It was expected that there were around four million mortalities in the age range of 20–79 years in 2019 due to diabetes all across the globe. In addition to this, more than one million children and adolescents were living with type-1 diabetes in 2019. To learn more about this report request a free sample copy @https://www.omrglobal.com/request- sample/l-carnitine-market A large number of people which is around 50% globally remain undiagnosed from diabetes. Several human and animal studies demonstrated the beneficial effect of taking L-carnitine supplementation. The L-carnitine improves body glucose utilization and controls the sugar level. Therefore, the rising incidence and prevalence of diabetes across the globe are anticipated to drive the growth of the global carnitine market. Apart from this, Depending on the indication, dietary supplements of L-carnitine at a dose rate of 20 to 500 mg/kg feed raise plasma L-carnitine levels in domestic and laboratory animals such as pigs, cow, dogs, birds and fish. Oral L- carnitine additives also increase the amount of L-carnitine in animal products such as eggs. The level of L- carnitine content in blood, liver and heart decreases significantly at birth. The new-born and suckling piglets, therefore, require external L-carnitine which is normally derived from colostrum milk. In addition, the beneficial effects of L-carnitine supplementation during growing and finishing time were also observed in the growth and metabolic tests with pigs. Therefore, the poultry farmers are making use of L-carnitine supplements in the animal feed. The rising adoption of the L-carnitine in making the animal feed is anticipated to make a huge contribution towards the growth of the L-carnitine market across the globe. Global L-Carnitine Market Segmentation By Process Type Bioprocess Chemical Synthesis
By Product Type Food & Pharmaceutical Grade Feed Grade By Application Animal Feed Healthcare Products Functional Drinks Others Global L-Carnitine Market – Segment by Region North America United States Canada Europe UK Germany Italy Spain France Rest of Europe Asia-Pacific China Japan India Rest of the Asia-Pacific Rest of the World
Company Profiles AIDP, Inc. Biosint S.p.A. Carbosynth, Ltd. Cayman Chemical Ceva Santé Animale S.A. Chengda Pharmaceuticals Co. Ltd. Huanggang Huayang Pharmaceutical Co. Ltd. Hubei Yuancheng Technology Co. Ltd. Kaiyuan Hengtai Chemical Co., Ltd. Lonza Group, Ltd. Merck KGaA Northeast Pharmaceutical Group Co., Ltd. Shanghai Kangxin Chemical Co., Ltd. Tokyo Chemical Industry Co., Ltd. Xinxiang Kangjian Chemical Co., Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/l-carnitine-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404